Down Over 60%, Is TransMedics Stock a Buy on the Dip?
TransMedics Group (NASDAQ: TMDX) was a top-performing stock that more than doubled in value during the months between the end…
108,975€
-0,11%
Echtzeit-Aktienkurs TransMedics Group Inc.
Bid:
Ask:
Nachrichten zur TransMedics Group Inc. Aktie
Why Transmedics Group Stock Plummeted 21% This Week
Shares of Transmedics Group (NASDAQ: TMDX) sank over 20% this week, according to data from S&P Global Market Intelligence. The…
Why TransMedics Stock Plummeted Today
Shares of leading organ transplant platform TransMedics (NASDAQ: TMDX) were down 14% as of noon ET on Wednesday, according to…
2 Hypergrowth Stocks That Are Screaming Buys in November
Growth investors have seen their fair share of bumps in the road the last few years, with some great businesses…
INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is Investigating Investor Claims Against TransMedics Group, Inc. and Encourages TMDX Investors with Losses to Contact the Firm
SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether TransMedics…
TransMedics Group, Inc. (TMDX) Q3 2024 Earnings Call Transcript
…
TransMedics Group: This Could Be One Of The Biggest Moats In A Decade
…
TransMedics: Organtransplantation neu gedacht! Der Markt für Organtransplantationen ist groß und unterrepräsentiert
TransMedics revolutioniert den Organtransport mit seinem von der FDA zugelassenen Organ Care System und verbessert die Organfunktionalität während des…
Revolutionäre Technologie und starkes Wachstum: Transmedics auf dem Weg nach oben nach einem neuen 200 USD-Ziel!
Transmedics (TMDX) bietet Organ Care-Systeme an, um den Transport von Organen zu verbessern. Mit den Systemen, die viele Aspekte der…
TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy
…
TransMedics Group, Inc. (TMDX) Q2 2024 Earnings Call Transcript
…
TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
…
TransMedics Group, Inc. (TMDX) Q1 2024 Earnings Call Transcript
…
TransMedics Group: Founder Led Company With Solid Potential
…
TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
…
TransMedics Group: Huge Opportunity In Organ Transplants
…
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TransMedics Group, Inc. on Behalf of TransMedics Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
TransMedics Group, Inc. (TMDX) Q4 2023 Earnings Call Transcript
…